R R

What is Idiopathic Multicentric Castleman Disease?

Idiopathic Multicentric Castleman Disease iMCD is a rare, life-threatening disorder characterized by the uncontrolled enlargement of lymph nodes in multiple areas of the body, accompanied by severe systemic inflammation.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What is Idiopathic Multicentric Castleman Disease?

Idiopathic Multicentric Castleman Disease iMCD is a rare, life-threatening disorder characterized by the uncontrolled enlargement of lymph nodes in multiple areas of the body, accompanied by severe systemic inflammation.

read more about idiopathic multicentric castleman disease ...

Copy this HTML:

Copy HTML Copied!

What is the Cause and What is the Difference from Unicentric Disease?

The cause of iMCD is unknown ("idiopathic"). It is believed to be caused by a severe, uncontrolled inflammatory response driven by overproduction of the cytokine IL-6. This differs from unicentric Castleman disease, which is confined to a single lymph node. iMCD is systemic, affecting multiple lymph nodes and major organ systems simultaneously.

What Symptoms Define the Systemic Inflammation?

Symptoms define a severe systemic inflammatory state. These include persistent fevers, drenching night sweats, unexplained weight loss, fluid retention, and nerve damage. The excessive inflammation damages organs like the liver and spleen and can lead to severe anemia.

How Does This Condition Impact Vision or Eye Health?

Idiopathic Multicentric Castleman Disease can directly impact eye health by causing severe inflammation and swelling in the orbit (the eye socket). This leads to proptosis (bulging of the eye) or visual disturbances. Inflammation of the orbital structures is a recognized, serious manifestation of the disease.

Diagnostic Procedures

Diagnosis relies on a lymph node biopsy to confirm the specific cellular changes characteristic of Castleman disease. Blood tests show extremely high levels of inflammatory markers and often low blood cell counts. Diagnosis requires ruling out other causes of lymph node swelling, such as lymphoma.

What are the Necessary Treatments?

Necessary treatments focus on suppressing the systemic inflammation. This involves high doses of corticosteroids and targeted immunotherapy drugs that block the inflammatory pathway (such as IL-6 antagonists). Chemotherapy may be used if the disease is severe or aggressive.

FAQs on Idiopathic Multicentric Castleman Disease

Is this disorder a type of cancer?

No, it is a severe, systemic inflammatory disorder, but its symptoms mimic lymphoma (cancer) and it is managed by oncologists.

Is this contagious?

No, it is an autoimmune/inflammatory disorder and is not contagious.

What is the prognosis?

The prognosis is serious, but targeted drug therapy has improved outcomes significantly.

When to See Your Doctor

Consult an oncologist if you have unexplained fever, weight loss, or swollen lymph nodes. iMCD can cause "Retinal Vasculitis" or orbital masses. PET scans and lymph node biopsies are essential medical tools for distinguishing this from malignant lymphoma.

References

Castleman Disease Collaborative Network. About iMCD (cdcn.org). 2024.

Mayo Clinic. Castleman Disease (mayoclinic.org). 2024.

StatPearls. Castleman Disease (ncbi.nlm.nih.gov). 2024.

American Cancer Society. Castleman Disease Overview (cancer.org). 2024.